Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuyuki Ono

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Rheumatology International|July 28, 2018
Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?Yoshifumi Tada, Satomi Inokuchi, Akihito Maruyama, et al.
Modern Rheumatology|August 26, 2022
Safety and efficacy of switching immunosuppressive drugs for maintenance treatment in patients with systemic lupus erythematosus: A retrospective cohort studyMasahiro Ayano, Yasutaka Kimoto, Hiroki Mitoma, et al.
The Journal of Clinical Investigation|November 10, 2007
TNF-alpha is critical for antitumor but not antiviral T cell immunity in miceThomas Calzascia, Marc Pellegrini, Håkan Hall, et al.
Modern Rheumatology Case Reports|March 15, 2021
IgG4-related disease presenting as a paraneoplastic syndrome: report of two cases and literature reviewMitsuteru Akahoshi, Yojiro Arinobu, Yusuke Kashiwado, et al.
Rheumatology (Oxford, England)|February 22, 2023
Anti-dsDNA IgE induces IL-4 production from basophils, potentially involved in B-cell differentiation in systemic lupus erythematosusSho Fujimoto, Yojiro Arinobu, Kohta Miyawaki, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|December 28, 2012
Successful treatment of immunodeficiency-associated EBV-negative lymphoproliferative disorders in rheumatoid arthritis by methotrexate withdrawal and prevention of its relapse by rituximab administrationNoriaki Kawano, Nobuyuki Ono, Shuro Yoshida, et al.
Modern Rheumatology|June 19, 2012
Four cases of MPO-ANCA-positive vasculitis with otitis media, and review of the literatureNobuyuki Ono, Kyoko Yoshihiro, Daisuke Oryoji, et al.
Case Reports in Rheumatology|October 10, 2015
Effectiveness of Certolizumab Pegol in Treating Rheumatoid Arthritis Patients with Persistent Inflamed Residual Mono- or Oligosynovitis Resistant to Prior TNF-α InhibitorsSyuichi Koarada, Masahiko Tsuboi, Mitsunori Komine, et al.
Rheumatology International|April 26, 2024
No clear influence of treatment escalation on flare prevention in serologically active clinically quiescent patients with systemic lupus erythematosus: a retrospective cohort studyMasahiro Ayano, Akie Hirata, Shoji Tokunaga, et al.
Arthritis Research & Therapy|September 14, 2021
HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective studyKazuo Kushimoto, Masahiro Ayano, Keisuke Nishimura, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Rheumatology International|July 28, 2018
Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?Yoshifumi Tada, Satomi Inokuchi, Akihito Maruyama, et al.
Modern Rheumatology|August 26, 2022
Safety and efficacy of switching immunosuppressive drugs for maintenance treatment in patients with systemic lupus erythematosus: A retrospective cohort studyMasahiro Ayano, Yasutaka Kimoto, Hiroki Mitoma, et al.
The Journal of Clinical Investigation|November 10, 2007
TNF-alpha is critical for antitumor but not antiviral T cell immunity in miceThomas Calzascia, Marc Pellegrini, Håkan Hall, et al.
Modern Rheumatology Case Reports|March 15, 2021
IgG4-related disease presenting as a paraneoplastic syndrome: report of two cases and literature reviewMitsuteru Akahoshi, Yojiro Arinobu, Yusuke Kashiwado, et al.
Rheumatology (Oxford, England)|February 22, 2023
Anti-dsDNA IgE induces IL-4 production from basophils, potentially involved in B-cell differentiation in systemic lupus erythematosusSho Fujimoto, Yojiro Arinobu, Kohta Miyawaki, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|December 28, 2012
Successful treatment of immunodeficiency-associated EBV-negative lymphoproliferative disorders in rheumatoid arthritis by methotrexate withdrawal and prevention of its relapse by rituximab administrationNoriaki Kawano, Nobuyuki Ono, Shuro Yoshida, et al.
Modern Rheumatology|June 19, 2012
Four cases of MPO-ANCA-positive vasculitis with otitis media, and review of the literatureNobuyuki Ono, Kyoko Yoshihiro, Daisuke Oryoji, et al.
Case Reports in Rheumatology|October 10, 2015
Effectiveness of Certolizumab Pegol in Treating Rheumatoid Arthritis Patients with Persistent Inflamed Residual Mono- or Oligosynovitis Resistant to Prior TNF-α InhibitorsSyuichi Koarada, Masahiko Tsuboi, Mitsunori Komine, et al.
Rheumatology International|April 26, 2024
No clear influence of treatment escalation on flare prevention in serologically active clinically quiescent patients with systemic lupus erythematosus: a retrospective cohort studyMasahiro Ayano, Akie Hirata, Shoji Tokunaga, et al.
Arthritis Research & Therapy|September 14, 2021
HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective studyKazuo Kushimoto, Masahiro Ayano, Keisuke Nishimura, et al.
Pageof 7